MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer-Reference-Cited by-同舟云学术

MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer

Published:2015-08-13 Issue:24 Volume:21 Page:5499-5510
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

García-García Celina,Rivas Martín A.,Ibrahim Yasir H.,Calvo María Teresa,Gris-Oliver Albert,Rodríguez Olga,Grueso Judit,Antón Pilar,Guzmán Marta,Aura Claudia,Nuciforo Paolo,Jessen Katti,Argilés Guillem,Dienstmann Rodrigo,Bertotti Andrea,Trusolino Livio,Matito Judit,Vivancos Ana,Chicote Irene,Palmer Héctor G.,Tabernero Josep,Scaltriti Maurizio,Baselga José,Serra Violeta

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the impact of green and roasted coffee extracts on colorectal cancer cells in a 3D cell culture model;Phytomedicine Plus;2024-08

2. Spike-in enhanced phosphoproteomics uncovers synergistic signaling responses to MEK inhibition in colon cancer cells;2024-05-15

3. p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells;PLOS ONE;2023-11-16

4. A review on mechanobiology of cell adhesion networks in different stages of sporadic colorectal cancer to explain its tumorigenesis;Progress in Biophysics and Molecular Biology;2022-11

5. Pharmacologic Inhibition of SHP2 Blocks Both PI3K and MEK Signaling in Low-epiregulin HNSCC via GAB1;Cancer Research Communications;2022-09-26